This research demonstrates bioinspired total synthesis of elisapterane diterpenoids, highlighting the role of computational tools in structure reassignment.
Herein, we describe our synthetic endeavors toward elisapterane and relevant diterpenoids through a bioinspired divergent strategy based on an unprecedented late-stage D-ring formation logic. The key tricyclic intermediate bearing a norneoelisabane skeleton could be efficiently prepared via an ODI-(5 + 2) cycloaddition/1,2-acyl migration cascade and a SmI2-mediated pinacol coupling/Grob fragmentation/deoxygenation orchestration. The synthesis of the misassigned structure of elisapterosin F led us to revisit the structure elucidation of these natural products. Application of NMR calculation-based in silico structure reassignment disclosed several unheeded structural mutations for elisapterane diterpenoids and accurately revised the structures of elisapterosins A, D, and F. With a computation-rerouted synthetic blueprint, we eventually accomplished collective total syntheses of elisapterosins A–F, alongside biogenetically related aberrarone, elisabanolide, and 3-epi-elisabanolide. By integrating our inference aided by computational tools with validation through total synthesis, this work exemplifies a modern case of total synthesis detective stories, demonstrating the power of computer-assisted structure elucidation (CASE) and the risks of analogical approaches for the structure assignment of natural products.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: